Royalty Pharma Price/Book Ratio 2019-2024 | RPRX

Royalty Pharma current price/book ratio as of January 18, 2025 is 2.94.

  • Royalty Pharma average price/book ratio for 2024 was 2.8, a 8.5% increase from 2023.
  • Royalty Pharma average price/book ratio for 2023 was 3.06, a 20.73% decline from 2022.
  • Royalty Pharma average price/book ratio for 2022 was 3.86, a 4.89% decline from 2021.

Price/book ratio can be defined as

Royalty Pharma Price/Book Ratio 2019-2024 | RPRX

  • Royalty Pharma average price/book ratio for 2024 was 2.8, a 8.5% increase from 2023.
  • Royalty Pharma average price/book ratio for 2023 was 3.06, a 20.73% decline from 2022.
  • Royalty Pharma average price/book ratio for 2022 was 3.86, a 4.89% decline from 2021.

Price/book ratio can be defined as

Related Stocks
Company NameMarket
Cap
American Express (AXP)$206.6B
Blackstone (BX)$119B
Moody's (MCO)$82B
Synchrony Financial (SYF)$24.8B
Orix Corp Ads (IX)$23.1B
Brookfield Asset Management (BAM)$23.1B
SoFi Technologies (SOFI)$15.4B
Equitable Holdings (EQH)$15.1B
Jefferies Financial Group (JEF)$14.7B
BB Seguridade Participacoes SA (BBSEY)$12.5B
Houlihan Lokey (HLI)$11.7B
Globe Life (GL)$9.4B
Daiwa Securities Group (DSEEY)$9B
Brookfield Wealth Solutions (BNT)$8B
Freedom Holding (FRHC)$7.8B
SouthState (SSB)$7.1B
StepStone Group (STEP)$6.7B
XP (XP)$6.1B
Blue Owl Capital (OBDC)$5.7B
Rithm Capital (RITM)$5.6B
Virtu Financial (VIRT)$5.4B
Lazard (LAZ)$5.3B
Upstart Holdings (UPST)$5.3B
Euronet Worldwide (EEFT)$4.3B
Core Scientific (CORZ)$3.9B
AXOS FINANCIAL, INC (AX)$3.8B
PJT Partners (PJT)$3.7B
HA Sustainable Infrastructure Capital (HASI)$3.2B
StoneX Group (SNEX)$3.1B
CI Financial (CIXXF)$3.1B